229 related articles for article (PubMed ID: 16979757)
1. Development and in vitro evaluation of a thiomer-based nanoparticulate gene delivery system.
Schmitz T; Bravo-Osuna I; Vauthier C; Ponchel G; Loretz B; Bernkop-Schnürch A
Biomaterials; 2007 Jan; 28(3):524-31. PubMed ID: 16979757
[TBL] [Abstract][Full Text] [Related]
2. Oral gene delivery: design of polymeric carrier systems shielding toward intestinal enzymatic attack.
Martien R; Loretz B; Schnürch AB
Biopolymers; 2006 Nov; 83(4):327-36. PubMed ID: 16609969
[TBL] [Abstract][Full Text] [Related]
3. Role of sulfhydryl groups in transfection? A case study with chitosan-NAC nanoparticles.
Loretz B; Thaler M; Bernkop-Schnürch A
Bioconjug Chem; 2007; 18(4):1028-35. PubMed ID: 17552491
[TBL] [Abstract][Full Text] [Related]
4. Chitosan-thioglycolic acid conjugate: an alternative carrier for oral nonviral gene delivery?
Martien R; Loretz B; Thaler M; Majzoob S; Bernkop-Schnürch A
J Biomed Mater Res A; 2007 Jul; 82(1):1-9. PubMed ID: 17265441
[TBL] [Abstract][Full Text] [Related]
5. A novel PEGylation of chitosan nanoparticles for gene delivery.
Zhang Y; Chen J; Zhang Y; Pan Y; Zhao J; Ren L; Liao M; Hu Z; Kong L; Wang J
Biotechnol Appl Biochem; 2007 Apr; 46(Pt 4):197-204. PubMed ID: 17147512
[TBL] [Abstract][Full Text] [Related]
6. Development and characterization of a new plasmid delivery system based on chitosan-sodium deoxycholate nanoparticles.
Cadete A; Figueiredo L; Lopes R; Calado CC; Almeida AJ; Gonçalves LM
Eur J Pharm Sci; 2012 Mar; 45(4):451-8. PubMed ID: 21986445
[TBL] [Abstract][Full Text] [Related]
7. Synergistic effects of conjugating cell penetrating peptides and thiomers on non-viral transfection efficiency.
Rahmat D; Khan MI; Shahnaz G; Sakloetsakun D; Perera G; Bernkop-Schnürch A
Biomaterials; 2012 Mar; 33(7):2321-6. PubMed ID: 22169137
[TBL] [Abstract][Full Text] [Related]
8. [Chitosan nanoparticles as gene vector: effect of particle size on transfection efficiency].
Yang XR; Zong L; Yuan XY
Yao Xue Xue Bao; 2007 Jul; 42(7):774-9. PubMed ID: 17882964
[TBL] [Abstract][Full Text] [Related]
9. Chitosan nanoparticle as gene therapy vector via gastrointestinal mucosa administration: results of an in vitro and in vivo study.
Zheng F; Shi XW; Yang GF; Gong LL; Yuan HY; Cui YJ; Wang Y; Du YM; Li Y
Life Sci; 2007 Jan; 80(4):388-96. PubMed ID: 17074366
[TBL] [Abstract][Full Text] [Related]
10. Arginine-chitosan/DNA self-assemble nanoparticles for gene delivery: In vitro characteristics and transfection efficiency.
Gao Y; Xu Z; Chen S; Gu W; Chen L; Li Y
Int J Pharm; 2008 Jul; 359(1-2):241-6. PubMed ID: 18479851
[TBL] [Abstract][Full Text] [Related]
11. Thiomer nanoparticles: stabilization via covalent cross-linking.
Barthelmes J; Dünnhaupt S; Hombach J; Bernkop-Schnürch A
Drug Deliv; 2011 Nov; 18(8):613-9. PubMed ID: 22111974
[TBL] [Abstract][Full Text] [Related]
12. Improved synthesis and in vitro characterization of chitosan-thioethylamidine conjugate.
Kafedjiiski K; Hoffer M; Werle M; Bernkop-Schnürch A
Biomaterials; 2006 Jan; 27(1):127-35. PubMed ID: 16045983
[TBL] [Abstract][Full Text] [Related]
13. Gene transfer by DNA/mannosylated chitosan complexes into mouse peritoneal macrophages.
Hashimoto M; Morimoto M; Saimoto H; Shigemasa Y; Yanagie H; Eriguchi M; Sato T
Biotechnol Lett; 2006 Jun; 28(11):815-21. PubMed ID: 16786247
[TBL] [Abstract][Full Text] [Related]
14. Folate mediated histidine derivative of quaternised chitosan as a gene delivery vector.
Morris VB; Sharma CP
Int J Pharm; 2010 Apr; 389(1-2):176-85. PubMed ID: 20117198
[TBL] [Abstract][Full Text] [Related]
15. [Feasibility of chitosan as gene therapy vehicle].
Wan YY; Zhang X; He YJ; Jiang WQ
Ai Zheng; 2005 Nov; 24(11):1408-11. PubMed ID: 16552973
[TBL] [Abstract][Full Text] [Related]
16. Preparation and evaluation of chitosan-DNA-FAP-B nanoparticles as a novel non-viral vector for gene delivery to the lung epithelial cells.
Mohammadi Z; Abolhassani M; Dorkoosh FA; Hosseinkhani S; Gilani K; Amini T; Najafabadi AR; Tehrani MR
Int J Pharm; 2011 May; 409(1-2):307-13. PubMed ID: 21356293
[TBL] [Abstract][Full Text] [Related]
17. Development of a novel method for the preparation of submicron particles based on thiolated chitosan.
Bernkop-Schnürch A; Heinrich A; Greimel A
Eur J Pharm Biopharm; 2006 Jun; 63(2):166-72. PubMed ID: 16527469
[TBL] [Abstract][Full Text] [Related]
18. Methoxy poly(ethylene glycol)--low molecular weight linear polyethylenimine-derived copolymers enable polyplex shielding.
Lungwitz U; Breunig M; Liebl R; Blunk T; Goepferich A
Eur J Pharm Biopharm; 2008 May; 69(1):134-48. PubMed ID: 18042362
[TBL] [Abstract][Full Text] [Related]
19. Improved chitosan-mediated gene delivery based on easily dissociated chitosan polyplexes of highly defined chitosan oligomers.
Köping-Höggård M; Vårum KM; Issa M; Danielsen S; Christensen BE; Stokke BT; Artursson P
Gene Ther; 2004 Oct; 11(19):1441-52. PubMed ID: 15269712
[TBL] [Abstract][Full Text] [Related]
20. Effects of alginate inclusion on the vector properties of chitosan-based nanoparticles.
Douglas KL; Piccirillo CA; Tabrizian M
J Control Release; 2006 Oct; 115(3):354-61. PubMed ID: 17045691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
